Search Results

• • 13,698 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Select Advisory Committee Recommends FDA Wait for Satraplatin Survival Results

  1

  Advisory Committee Recommends FDA Wait for Satraplatin Survival Results

  From:Oncology (Vol. 21, Issue 9) Peer-Reviewed

  Aug. 1, 200793 words Brief article 1580LGPC Biotech announced that the Oncologic Drugs Advisory Committee (ODAC) for the US Food and Drug Administration (FDA) recommended (12-0) that the FDA should wait for the final survival analysis of the SPARC trial...
• Select Young plans management reforms at FDA; the new FDA commissioner is also concentrating on learning the ways of Washington

  2

  Young plans management reforms at FDA; the new FDA commissioner is also concentrating on learning the ways of Washington

  Author:Marjorie SunFrom:Science (Vol. 227) Peer-Reviewed

  Jan. 18, 19851,572 words Biography Six months ago, the Reagan Administration appointed Frank E. Young, dean of the University of Rochester medical school, to be commissioner of the Food and Drug Administration (FDA), which has broad authority over the...
• Select FDA approves first drug for resistant TB

  3

  FDA approves first drug for resistant TB

  Author:Donya CurrieFrom:The Nation's Health (Vol. 43, Issue 1)

  Feb. 2013174 words Brief article 1470LThe U.S. Food and Drug Administration has approved Sirturo, or bedaquiline, as part of a combination therapy to treat adults with multidrug-resistant pulmonary tuberculosis. The drug is the first to be approved by...
• Select FDA app roves Botox for overactive bladder

  4

  FDA app roves Botox for overactive bladder

  Author:Alicia AultFrom:OB GYN News (Vol. 48, Issue 2)

  Feb. 2013322 words Brief article 1690LThe Food and Drug Administration approved Botox for patients with overactive bladder who have contraindications to or don't respond to anticholinergic medications. "Clinical studies have demonstrated Botox's ability...
• Select FDA approves 39 new drugs

  5

  FDA approves 39 new drugs

  Author:Jane AndersonFrom:Clinical Psychiatry News (Vol. 41, Issue 2)

  Feb. 2013100 words Brief article 1530LThe Food and Drug Administration approved 39 new drugs in 2012, making it the most prolific year for drug approvals since 2004 and marking a major increase over the 30 drugs approved in 2011. Drugs that won FDA approval...
• Select Newly labeled sunscreens surface on shelves

  6

  Newly labeled sunscreens surface on shelves

  Author:Alicia AultFrom:Skin & Allergy News (Vol. 44, Issue 2)

  Feb. 2013964 words Article 1410LSunscreens that have proven their protective ability and feature updated, more consumer-friendly labeling are hitting store shelves, but they currently share space with older products that may not have passed muster...
• Select Current assays for HIV-1 diagnostics and antiretroviral therapy monitoring: challenges and possibilities

  7

  Current assays for HIV-1 diagnostics and antiretroviral therapy monitoring: challenges and possibilities

  Authors:Sabrina Wai-Chi To, Jonathan Hon-Kwan Chen, and Wing-Cheong YamFrom:Future Virology (Vol. 8, Issue 4)

  Apr. 201311,237 words Article 1380LAuthor(s): Sabrina Wai-Chi To 1 , Jonathan Hon-Kwan Chen 1 , Wing-Cheong Yam [*] 2 Keywords * determination; drug resistance monitoring; HIV-1 diagnostic assays; tropism; ultradeep sequencing; viral load...
• Select FDA approves canagliflozin for type 2 diabetes: agency is requiring five postmarketing studies, including a cardiovascular outcomes trial

  8

  FDA approves canagliflozin for type 2 diabetes: agency is requiring five postmarketing studies, including a cardiovascular outcomes trial

  Author:Alicia AultFrom:Internal Medicine News (Vol. 46, Issue 7)

  Apr. 15, 2013357 words Brief article 1340LThe Food and Drug Administration has approved canagliflozin, an oral, once-daily therapy for adult patients with type 2 diabetes. The drug will be marketed by Janssen Pharmaceuticals as Invokana. Canagliflozin is...
• Select FDA backs abuse-deterring OxyContin, thwarts generics

  9

  FDA backs abuse-deterring OxyContin, thwarts generics

  Author:Mitchel L. ZolerFrom:Internal Medicine News (Vol. 46, Issue 8)

  May 1, 2013355 words Brief article 1590LIn an eleventh-hour action that derailed the possibility of generic formulations of controlled-release oxycodone (OxyContin) from appearing on the U.S. market anytime soon, the Food and Drug Administration announced...
• Select Should there be an app for that? Controversies of diagnosing melanoma with your smartphone

  10

  Should there be an app for that? Controversies of diagnosing melanoma with your smartphone

  Authors:Jacqueline F Moreau and Laura K FerrisFrom:Expert Review of Dermatology (Vol. 8, Issue 3) Peer-Reviewed

  June 20131,369 words Editorial 1490LAuthor(s): Jacqueline F Moreau 1 , Laura K Ferris [*] 2 Keywords : electronic media; melanoma; public health; telemedicine Smartphone use in the USA has increased rapidly in the past decade. Today, more than...
• Select Three more states limit indoor tanning

  11

  Three more states limit indoor tanning

  Author:Kim KrisbergFrom:The Nation's Health (Vol. 43, Issue 6)

  Aug. 2013188 words Brief article 1230LConnecticut, Nevada and Texas have joined the movement to restrict indoor tanning among minors. In early June, Nevada Gov. Brian Sandoval signed legislation banning indoor tanning among residents younger than 18...
• Select Findings on Obesity Detailed by Investigators at University of Toronto

  12

  Findings on Obesity Detailed by Investigators at University of Toronto

  From:Obesity, Fitness & Wellness Week

  Dec. 7, 2013298 words Brief article 1370LBy a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Diet and Nutrition Disorders have been presented. According to news reporting originating from Toronto, Canada, by NewsRx...
• Select Armodafinil shows efficacy in bipolar depression

  13

  Armodafinil shows efficacy in bipolar depression

  Author:Mitchel L. ZolerFrom:Internal Medicine News (Vol. 46, Issue 19)

  Nov. 15, 2013570 words Article 1450LAT THE ECNP CONGRESS BARCELONA--Armodafinil, a drug with Food and Drug Administration approval to treat excessive dleepiness and narcolepsy, showed efficacy for improving concentration, energy, and appetite in a...
• Select Practical use of glucagon-like peptide-1 receptor agonist therapy in primary care

  14

  Practical use of glucagon-like peptide-1 receptor agonist therapy in primary care

  Author:Timothy S. ReidFrom:Clinical Diabetes (Vol. 31, Issue 4) Peer-Reviewed

  Fall 20136,820 words Article 1690LGlucagon-like peptide-1 (GLP-1) receptor agonists are one of the newer classes of medications for the treatment of adults with type 2 diabetes. The GLP-1 receptor agonist class became available in 2005 in the United...
• Select Tenofovir-based HIV pre-exposure prophylaxis

  15

  Tenofovir-based HIV pre-exposure prophylaxis

  Author:Lynn A PaxtonFrom:Future Virology (Vol. 8, Issue 12)

  Dec. 20139,307 words Report 1460LAuthor(s): Lynn A Paxton 1 Keywords * emtricitabine; HIV; HIV prevention; PrEP; tenofovir Despite remarkable advances in the fields of HIV treatment and prevention in the past decade, the most recent UNAIDS...
• Select FDA and NIH create first-of-kind tobacco centers of regulatory science

  16

  FDA and NIH create first-of-kind tobacco centers of regulatory science

  From:Spectroscopy (Vol. 28, Issue 11)

  Nov. 2013487 words Article 1570LThe United States Food and Drug Administration (FDA) and the National Institutes of Health (NIH), as part of an ongoing interagency partnership, have awarded a total of up to $53 million to fund tobacco-related research...
• Select Can approach to campus meningitis outbreaks last?

  17

  Can approach to campus meningitis outbreaks last?

  Author:Patrice WendlingFrom:Internal Medicine News (Vol. 47, Issue 5)

  Mar. 15, 2014716 words Article 1560LThe incidence of all meningococcal serotypes is in decline, except for the spike in serogroup B on college campuses. "Although we do not expect an increase in MenB outbreaks on college campuses, the CDC has recently...
• Select Injectable testosterone approved for hypogonadism

  18

  Injectable testosterone approved for hypogonadism

  Author:Elizabeth MechcatieFrom:Internal Medicine News (Vol. 47, Issue 6)

  Apr. 1, 2014440 words Article 1530LA long-acting intramuscular formulation of testosterone has been approved by the Food and Drug Administration for treating hypogonadism, with a label that includes a boxed warning about the risks of pulmonary oil...
• Select Reports from Tufts University Describe Recent Advances in Methicillin-Resistant Staphylococcus aureus (The Efficacy of Daptomycin Versus Vancomycin for Methicillin-Resistant Staphylococcus aureus Bloodstream Infection in Patients With Impaired ...)

  19

  Reports from Tufts University Describe Recent Advances in Methicillin-Resistant Staphylococcus aureus (The Efficacy of Daptomycin Versus Vancomycin for Methicillin-Resistant Staphylococcus aureus Bloodstream Infection in Patients With Impaired ...)

  From:Obesity, Fitness & Wellness Week

  July 12, 2014451 words Report 1400LBy a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on MRSA is the subject of a report. According to news reporting originating from Boston, Massachusetts, by NewsRx correspondents,...
• Select Prospective evaluation of 2% (w/v) alcoholic chlorhexidine gluconate as an antiseptic agent for blood donor arm preparation

  20

  Prospective evaluation of 2% (w/v) alcoholic chlorhexidine gluconate as an antiseptic agent for blood donor arm preparation

  Authors:Sweta Shah, Nidhi Mehta, and Sweta JadhavFrom:Asian Journal of Transfusion Science (Vol. 8, Issue 2) Peer-Reviewed

  July-December 20142,598 words Clinical report 1470LByline: Sweta. Shah, Nidhi. Mehta, Sweta. Jadhav Aim: A prospective study was undertaken to evaluate the use of 2% (w/v) alcoholic chlorhexidine gluconate (2% AlcCHG) in donor arm preparation, to monitor the...